Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2022-04-04 00:00:00 ET · period of report 2022-04-01 · accession 0001162194-22-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-04-04 | 2022-04-01 | LAB | BARTHELEMY NICOLAS | Dir | M - OptEx | $3.74 | +21.0K | 204.1K | +11% | +$78.5K |
| D | 2022-04-04 | 2022-04-01 | LAB | BARTHELEMY NICOLAS | Dir | M - OptEx | $3.74 | -21.0K | 0 | -100% | -$78.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-01 | M | A | 20,993 | $3.74 | 204,077 | I The Barthelemy 2001 Trust | — | — | |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-04-01 | M | D | 20,993 | $3.74 | 0 | D | $3.74 · 2021-06-23 to 2030-06-23 | 20,993 Common Stock |